Search Results 1281-1290 of 17106 for monoclonal antibody
Chemotherapy, immunotherapy, hormonal therapy, and monoclonal antibodies (but excluding nitrosourea, mitomycin-C, targeted therapy) ≤ 28 days prior to ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
... antibody to standard-of-care chemotherapy. “Our hope is that the antibody will neutralize the IL-13 in patients, making pancreatic tumors more susceptible ...
... antibodies against their donors are at a greater risk of rejection of their transplanted organs. Participation eligibility. Participant eligibility includes ...
Serum monoclonal protein ≥ 1.0 g/dl by protein electrophoresis;; > 200 mg of monoclonal protein in the urine on 24-hour electrophoresis;; If either serum or ...
... monoclonal antibody (e.g., rituximab) in combination with chemotherapy. Measurable disease as defined below: Fluorodeoxyglucose (FDG)-avid lymphomas ...
Has previously received any CGRP ligand or receptor targeted monoclonal antibody. Eligibility last updated 1/19/22. Questions regarding updates should be ...
Convalescent Plasma: A Therapy for COVID-19? Kate Ledger. April 6, 2020. Science Saturday: The importance of antibody testing in addressing COVID-19 featured ...
No prior anti-amyloid monoclonal antibody treatments or therapeutic trials targeting amyloid or tau prior to initiating study. Tracer comparison sub-sample ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.